Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.

Kolberg HC, Schumacher J, Erber R, Braun M, Fasching PA, Grischke EM, Schem C, Lux MP, Deryal M, Hoffmann O, Heinrich B, Kunz G, Lübbe K, Krabisch P, Hartmann A, Räth P, Kasimir-Bauer S, Kolberg-Liedtke C

Open source

DOI: 10.1158/1078-0432.ccr-25-1288
Published: 2025 Nov 14
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-1288,
  title = {Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.},
  author = {Kolberg HC and Schumacher J and Erber R and Braun M and Fasching PA and Grischke EM and Schem C and Lux MP and Deryal M and Hoffmann O and Heinrich B and Kunz G and Lübbe K and Krabisch P and Hartmann A and Räth P and Kasimir-Bauer S and Kolberg-Liedtke C},
  year = {2025},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-1288},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-1288}
}

RIS

TY  - JOUR
TI  - Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.
AU  - Kolberg HC
AU  - Schumacher J
AU  - Erber R
AU  - Braun M
AU  - Fasching PA
AU  - Grischke EM
AU  - Schem C
AU  - Lux MP
AU  - Deryal M
AU  - Hoffmann O
AU  - Heinrich B
AU  - Kunz G
AU  - Lübbe K
AU  - Krabisch P
AU  - Hartmann A
AU  - Räth P
AU  - Kasimir-Bauer S
AU  - Kolberg-Liedtke C
PY  - 2025
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-25-1288
UR  - https://doi.org/10.1158/1078-0432.ccr-25-1288
ER  -

APA

HC, K., J, S., R, E., M, B., PA, F., EM, G., C, S., MP, L., M, D., O, H., B, H., G, K., K, L., P, K., A, H., P, R., S, K., & C, K. (2025). Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-1288

Source records

pubmed · retrieved 2026-09-26T18:58:11.560Z